198 related articles for article (PubMed ID: 2422886)
1. Role of paf-acether and related ether-lipid metabolism in platelets.
Chignard M; Coëffier E; Benveniste J
Adv Exp Med Biol; 1985; 192():309-26. PubMed ID: 2422886
[No Abstract] [Full Text] [Related]
2. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
3. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
4. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Kornecki E; Ehrlich YH; Lenox RH
Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
7. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
[TBL] [Abstract][Full Text] [Related]
8. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.
Kinlough-Rathbone RL; Packham MA; Reimers HJ; Cazenave JP; Mustard JF
J Lab Clin Med; 1977 Oct; 90(4):707-19. PubMed ID: 333044
[No Abstract] [Full Text] [Related]
11. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
12. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
Hurst JS; Slater TF; Lang J; Juergens G; Zollner H; Esterbauer H
Chem Biol Interact; 1987 Feb; 61(2):109-24. PubMed ID: 3103933
[TBL] [Abstract][Full Text] [Related]
13. Release of acetylhydrolase from platelets on aggregation with platelet-activating factor.
Suzuki Y; Miwa M; Harada M; Matsumoto M
Eur J Biochem; 1988 Feb; 172(1):117-20. PubMed ID: 3345757
[TBL] [Abstract][Full Text] [Related]
14. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
15. Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
Juhan-Vague I; Chignard M; Poisson C; Roul C; Billerey M; Buonocore M; Driss F; Vague P; Benveniste J
Thromb Res; 1985 Apr; 38(1):83-9. PubMed ID: 3923649
[TBL] [Abstract][Full Text] [Related]
16. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
Steiner M; Landolfi R; Motola NC; Turcotte JG
Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
20. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen.
Vargaftig BB; Joseph D; Wal F; Marlas G; Chignard M; Chevance LG
Eur J Pharmacol; 1983 Aug; 92(1-2):57-68. PubMed ID: 6628537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
